Literature DB >> 15847748

[Clinical-epidemiological characteristics and antiretroviral treatment trends in a cohort of HIV infected patients. The PISCIS Project].

Angeles Jaén1, Jordi Casabona, Anna Esteve, Jose M Miró, Cristina Tural, Elena Ferrer, Melchor Riera, Ferran Segura, Lluís Force, Omar Sued, Josep Vilaró, Angels Masabeu, Isabel García, Esther Dorca, Jordi Altès, Gemma Navarro, Daniel Podzamczer, Concepción Villalonga, Bonaventura Clotet, Josep M Gatell.   

Abstract

BACKGROUND AND
OBJECTIVE: The aims of this study were to describe the process of implementation of the PISCIS cohort, and to describe the clinical and epidemiological characteristics and trends of antiretroviral treatment (ART) among patients enrolled from 1998 through 2003. PATIENTS AND
METHOD: Prospective cohort study of HIV-infected patients aged > or = 16 years newly attended in 10 Catalonian hospitals and one Balearic Islands hospital. Analysis were done using the Mantel's chi2 test for trend.
RESULTS: A total of 5,968 patients (mean age 39 yrs; 75% men) were recruited with a mean follow-up of 26.4 months (13,130 person-years). A total of 2,763 patients were newly diagnosed and among these, the most frequent transmission route was the heterosexual one (43%), followed by homosexual (31%). We observed an increasing trend in the proportion of persons < 35 years and immigrants. Among newly diagnosed, 43% had < 200 CD4 T cells/microl in the nearest determination from HIV diagnosis. In the year 2003, 83% of patients were on ART. A decrease of the protease inhibitor-based regimen (from 85% in 1998 to 25% in 2003; p < 0.001) and an increase of nucleoside and non-nucleoside analogue reverse transcriptase inhibitors-containing regimens were observed over time among naive patients who started ART with three or more drugs.
CONCLUSIONS: HIV infected patients' cohorts are feasible in our setting and are an important tool in clinical and public health. The heterosexual route of transmission was the most frequent among newly diagnosed patients. The diagnosis delay is high and, on the other hand, ARV regimens have been changing according to the recommended guidelines.

Entities:  

Mesh:

Year:  2005        PMID: 15847748     DOI: 10.1157/13073938

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  10 in total

1.  Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics.

Authors:  Margaret T May; Robert S Hogg; Amy C Justice; Bryan E Shepherd; Dominique Costagliola; Bruno Ledergerber; Rodolphe Thiébaut; M John Gill; Ole Kirk; Ard van Sighem; Michael S Saag; Gemma Navarro; Paz Sobrino-Vegas; Fiona Lampe; Suzanne Ingle; Jodie L Guest; Heidi M Crane; Antonella D'Arminio Monforte; Jörg J Vehreschild; Jonathan A C Sterne
Journal:  Int J Epidemiol       Date:  2012-11-12       Impact factor: 7.196

2.  Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries.

Authors:  Marcel Zwahlen; Ross Harris; Margaret May; Robert Hogg; Dominique Costagliola; Frank de Wolf; John Gill; Gerd Fätkenheuer; Charlotte Lewden; Mike Saag; Sholmo Staszewski; Antonella d'Arminio Monforte; Jordi Casabona; Fiona Lampe; Amy Justice; Viktor von Wyl; Matthias Egger
Journal:  Int J Epidemiol       Date:  2009-10-09       Impact factor: 7.196

3.  Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?

Authors:  Michael J Mugavero; Margaret May; Ross Harris; Michael S Saag; Dominique Costagliola; Matthias Egger; Andrew Phillips; Huldrych F Günthard; Francois Dabis; Robert Hogg; Frank de Wolf; Gerd Fatkenheuer; M John Gill; Amy Justice; Antonella D'Arminio Monforte; Fiona Lampe; Jose M Miró; Schlomo Staszewski; Jonathan A C Sterne
Journal:  AIDS       Date:  2008-11-30       Impact factor: 4.177

4.  Differences between migrants and Spanish-born population through the HIV care cascade, Catalonia: an analysis using multiple data sources.

Authors:  J Reyes-Urueña; C Campbell; C Hernando; N Vives; C Folch; L Ferrer; L Fernández-López; A Esteve; J Casabona
Journal:  Epidemiol Infect       Date:  2017-03-08       Impact factor: 4.434

5.  Imputation of the Date of HIV Seroconversion in a Cohort of Seroprevalent Subjects: Implications for Analysis of Late HIV Diagnosis.

Authors:  Paz Sobrino-Vegas; Santiago Pérez-Hoyos; Ronald Geskus; Belén Padilla; Ferrán Segura; Rafael Rubio; Jorge Del Romero; Jesus Santos; Santiago Moreno; Julia Del Amo
Journal:  AIDS Res Treat       Date:  2011-10-15

6.  Epidemiological and clinical features, response to HAART, and survival in HIV-infected patients diagnosed at the age of 50 or more.

Authors:  MaMercedes Nogueras; Gemma Navarro; Esperança Antón; Montserrat Sala; Manel Cervantes; MaJosé Amengual; Ferran Segura
Journal:  BMC Infect Dis       Date:  2006-11-06       Impact factor: 3.090

7.  Factors associated with tuberculosis as an AIDS-defining disease in an immigration setting.

Authors:  Vicente Martín; Patricia García de Olalla; Angels Orcau; Joan A Caylà
Journal:  J Epidemiol       Date:  2011-02-12       Impact factor: 3.211

8.  Estimating the HIV undiagnosed population in Catalonia, Spain: descriptive and comparative data analysis to identify differences in MSM stratified by migrant and Spanish-born population.

Authors:  Juliana Maria Reyes-Urueña; Colin N J Campbell; Núria Vives; Anna Esteve; Juan Ambrosioni; Cristina Tural; Elena Ferrer; Gemma Navarro; Lluis Force; Isabel García; Àngels Masabeu; Josep M Vilaró; Patricia García de Olalla; Joan Artur Caylà; Josep M Miró; Jordi Casabona
Journal:  BMJ Open       Date:  2018-02-28       Impact factor: 2.692

9.  Human papillomavirus infection in HIV-1 infected women in Catalonia (Spain): implications for prevention of cervical cancer.

Authors:  Valeria Stuardo; Cristina Agustí; José Manuel Godinez; Alexandra Montoliu; Aureli Torné; Antoni Tarrats; Carmen Alcalde; Dolores Martín; Eulalia Fernández-Montoli; Cristina Vanrell; Josefa Solé; Yolanda Canet; José Manuel Marqueta; Jadiyettu Mohamed; Isabel Cuenca; Montserrat Lonca; Guillem Sirera; Elena Ferrer; Pere Domingo; Belen Lloveras; Josep María Miro; Silvia De Sanjosé; Jordi Casabona
Journal:  PLoS One       Date:  2012-10-30       Impact factor: 3.240

Review 10.  Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.

Authors:  Jonathan A C Sterne; Margaret May; Dominique Costagliola; Frank de Wolf; Andrew N Phillips; Ross Harris; Michele Jönsson Funk; Ronald B Geskus; John Gill; François Dabis; Jose M Miró; Amy C Justice; Bruno Ledergerber; Gerd Fätkenheuer; Robert S Hogg; Antonella D'Arminio Monforte; Michael Saag; Colette Smith; Schlomo Staszewski; Matthias Egger; Stephen R Cole
Journal:  Lancet       Date:  2009-04-08       Impact factor: 79.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.